Boerrigter, G., Costello-Boerrigter, L. C., Harty, G. J., & Burnett, J. C. (2011). Bioavailability of intravenous versus subcutaneous administration of the dual GC-A and GC-B designer natriuretic peptide cenderitide in healthy canines. BioMed Central.
Dyfyniad Arddull ChicagoBoerrigter, Guido, Lisa C. Costello-Boerrigter, Gail J. Harty, and John C. Burnett. Bioavailability of Intravenous Versus Subcutaneous Administration of the Dual GC-A and GC-B Designer Natriuretic Peptide Cenderitide in Healthy Canines. BioMed Central, 2011.
Dyfyniad MLABoerrigter, Guido, Lisa C. Costello-Boerrigter, Gail J. Harty, and John C. Burnett. Bioavailability of Intravenous Versus Subcutaneous Administration of the Dual GC-A and GC-B Designer Natriuretic Peptide Cenderitide in Healthy Canines. BioMed Central, 2011.